Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) improves symptoms more effectively than natural resolution over time in individuals with ongoing symptomatic COVID-19 ...

C OVID-19 may leave a lasting impression on the brain, even in people who fully recover from their infection. New research ...

In a recent study published in the journal Nature, a group of researchers analyzed early cellular response dynamics to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in seronegative ...

In light of the ongoing threat posed by new viruses following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which led to the COVID-19 pandemic, new antiviral drugs ...

This chapter presents nine conclusions derived by the committee from evidence presented throughout the report. This chapter does not include references. Citations to support the text and conclusions ...

Researchers have discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly ...

New study reveals how lingering spike protein in the brain's borders could explain long-term COVID-19 neurological symptoms and highlight vaccines' protective role. Study: Persistence of spike protein ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

During the first few years of the COVID-19 pandemic, the virus SARS-CoV-2 was detected in an increasing number of non-human animal species. This included many wild animal species as well as domestic ...

Shi Zhengli, a leading virologist, became known as "Bat Woman" for her work on coronaviruses. She has spent decades studying bat-borne diseases, tracing their origins, and analyzing their potential ...